pi the digital currency, Overview

Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Huazhi Liquor Store: It is planned to distribute a cash dividend of 8.09 yuan for every 10 shares. Huazhi Liquor Store announced that the company's profit distribution plan for the first three quarters of 2024 has been approved by the shareholders' meeting. The company will distribute a cash dividend of RMB 8.09 to all shareholders for every 10 shares based on the existing total share capital of 417 million shares and the share capital of 408 million shares after 9,098,100 shares have been repurchased in the repurchase special securities account. The total amount of cash dividends actually distributed was 330 million. The distribution of rights and interests in date of record is December 19th, 2024, and the ex-dividend date is December 20th, 2024. This dividend does not involve bonus shares and capitalization of capital reserve.Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan. Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan, accounting for 10.48% of the total turnover of the day. The transaction price was 61.25 yuan, which was the same as the market closing price of 61.25 yuan.

Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.Nanxin Technology: The equity of shareholders Shunwei Technology and its concerted actions changed to less than 5%. Nanxin Technology announced that the shareholders of the company Shunwei Technology and its concerted actions Hangzhou Shunying, Wuhan Shunying and Wuhan Shunhong reduced their holdings of the company's shares and passively diluted their equity, and the total number of shares held by the company changed from 30,843,800 shares to 21,272,800 shares, accounting for 7.2826% to 4.9999% of the company's total share capital, no longer.Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.

Polish interest rate setter Nolov Ski: The discussion on interest rate reduction may start in March, and then a decision on interest rate reduction will be made soon.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.